Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 5/20 | 0.37 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6737771 | 1.00 | KIF11 (0.37) | KIF11KCNN4TAAR1CYP1A2CYP2D6 | |
| SCHEMBL2260217 | 0.83 | KIF11 (0.38) | KIF11KCNN4TAAR1CYP1A2CYP2D6 | |
| SCHEMBL9563235 | 0.75 | GABRA1 (0.41) | KIF11KCNN4TAAR1MAPT | |
| SCHEMBL2230699 | 0.75 | GABRA1 (0.41) | KIF11KCNN4TAAR1CYP1A2CYP2D6 | |
| SCHEMBL8084805 | 0.73 | GABRA1 (0.41) | KIF11KCNN4TAAR1CYP1A2CYP2D6 | |
| SCHEMBL239497 | 0.72 | KCNN4 (0.44) | KIF11KCNN4TAAR1CYP1A2CYP2D6 | |
| SCHEMBL9576011 | 0.71 | KIF11 (0.40) | KIF11KCNN4TAAR1CYP2D6 | |
| SCHEMBL11689791 | 0.71 | KIF11 (0.35) | KIF11 | |
| Hydrochloric Acid SCHEMBL27784459 | 0.70 | KCNN4 (0.43) | KIF11KCNN4TAAR1CYP1A2CYP2D6 | |
| SCHEMBL30182809 | 0.70 | KIF11 (0.32) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022082425-A1 | INKJET-USE HARDENABLE COMPOSITION, HARDENER, AND FLEXIBLE PRINTED CIRCUIT BOARD | 律胜科技股份有限公司 | 2022-04-28 | — | — | WO | disclosed |